Albert Cha
Independent ChairmanDr. Albert Cha, M.D., Ph.D., is Independent Chairman of Ascendis Pharma A/S from May 28, 2021. Dr. Cha serves on external advisory board of Rice Biotech Launch Pad. Dr. Cha joined the Ascendis Pharma A/S in November 2014. Dr. Cha was Independent Director of Ascendis Pharma A/S from November 2014 to May 28, 2021. Dr. Cha is Director of APT Pharmaceuticals, Inc. Dr. Cha is Director of TRIA Beauty, Inc. from July 2008. Dr. Cha joined the TRIA Beauty, Inc. in July 2008. Dr. Cha is Observer of Scorpion Therapeutics, Inc. from July 2024. Dr. Cha is Managing Partner of Frazier Life Sciences Management, LP. Dr. Cha joined the Frazier Life Sciences Management, LP in 2021. Dr. Cha is Managing Partner of Frazier Management, L.L.C. from 2021. Dr. Cha joined the Frazier Management, L.L.C. in 2021. Dr. Cha focuses on Life Sciences. Dr. Cha was Director of Biohaven Pharmaceutical Holding Company Ltd. from February 2017 to September 07, 2018. Dr. Cha was employed at Biohaven Pharmaceutical Holding Company Ltd. from February 2017 to September 07, 2018. Dr. Cha was Director of Ceptaris Therapeutics Inc. Dr. Cha was Managing Partner of Vivo Capital, LLC. Dr. Cha was Partner of Vivo Capital, LLC from 2003. Dr. Cha joined the Vivo Capital, LLC in 2000. Dr. Cha was Director of Vicept Therapeutics, Inc. Dr. Cha was Independent Director of Sierra Oncology, Inc. Dr. Cha was employed at Sierra Oncology, Inc. from April 2014 to June 16, 2016. Dr. Cha was Independent Director of Carbylan Therapeutics, Inc. Dr. Cha joined the Carbylan Therapeutics, Inc. in November 2007. Dr. Cha was Non-Executive Director of AirXpanders, Inc. Dr. Cha was employed at AirXpanders, Inc. until May 17, 2016. He serves as chairman of the board of Ascendis Pharma. Dr. Cha was Independent Director of Aclaris Therapeutics, Inc. Dr. Cha joined the Aclaris Therapeutics, Inc. in August 2012. Dr. Cha was Independent Director of KalVista Pharmaceuticals, Inc. from November 22, 2016 to October 4, 2024. Dr. Cha was employed at KalVista Pharmaceuticals, Inc. from November 22, 2016 to October 4, 2024. Dr. Cha was Director of Merz Aesthetics, Inc. Dr. Cha was employed at Merz Aesthetics, Inc. from June 2002 to February 06, 2009. Dr. Cha was Director of Angiogenix, Inc. Dr. Cha was Director of Neomend, Inc. Dr. Cha was Director of Essentialis, Inc. Dr. Cha was Director of NextWave Pharmaceuticals, Inc. Dr. Cha was Independent Director of Menlo Therapeutics Inc. from November 2015 to March 2019. Dr. Cha was employed at Menlo Therapeutics Inc. from November 2015 to March 2019. Dr. Cha was Director of Biodel Inc. Dr. Cha was employed at Biodel Inc. from July 2006 to June 05, 2008. Dr. Cha is CEO & Director of Frazier Life Sciences Acquisition Corp II from August 2026. Dr. Cha joined the Frazier Life Sciences Acquisition Corp II in August 2026. Dr. Cha has B.S. in Electrical Engineering from Stanford University, M.S. in Electrical Engineering from Stanford University, Ph.D. in Neuroscience from UCLA, School of Medicine, M.D. in Neuroscience from UCLA, School of Medicine.
Positions
- Company NameAscendis Pharma A/SStock CodeASNDPositionIndependent ChairmanColleagues
- JMJan Moller MikkelsenPresident, CEO, Member of Executive Board & Executive Director
- ACAlbert ChaIndependent Chairman
- STScott T. SmithCFO, Executive VP & Member of Executive Board
- PAPedersen Anni Lotte Kirstine SonderbjergExecutive VP, Chief Administrative Officer & Member of the Executive Board
- MWMichael Wolff JensenExecutive VP, Chief Legal Officer & Member of the Executive Board
- MBMads BodenhoffSenior VP, Head of Finance & Principal Accounting Officer
- LHLars HoltugIndependent Director
- LBLisa Bright MorrisonIndependent Director
- SISiham ImaniIndependent Director
- Company NameFrazier Life Sciences Acquisition Corp. IIStock CodeFLSCPositionCEO & Director
